BIOMARIN PHARMACEUTICAL INC: capex
| Value | {"amount": 23607000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-03-31 |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:10.627213+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ee72d759-4b87-4eb0-a296-c36d6a4fd4ad
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-15-003273Retrieved: 2026-08-19T10:17:10.627213+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/capex/2014-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ee72d759-4b87-4eb0-a296-c36d6a4fd4ad
History
- supersedes {"amount": 24177000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001193125-14-179407)